Xenon Pharmaceuticals Inc

Company Snapshot
200-3650 Gilmore Way
Burnaby, BC V5G 4W8
Canada
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 104
http://www.xenon-pharma.com
Please select from the dropdown
Company Financials

2018
2019
2020
Gross Profit
$6,829,000
Operating Income
($38,016,000)
($42,819,000)
($31,301,000)
Net Income
($34,497,000)
($41,595,000)
($28,837,000)
2018
Gross Profit
Operating Income
($38,016,000)
Net Income
($34,497,000)
2019
Gross Profit
$6,829,000
Operating Income
($42,819,000)
Net Income
($41,595,000)
2020
Gross Profit
Operating Income
($31,301,000)
Net Income
($28,837,000)
The above data on Xenon Pharmaceuticals Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Simon Pimstone
Chief Executive Officer and Director
$754,277
$2,154,135
$33,499
$2,941,911
Simon Pimstone
$2,941,911
Chief Executive Officer and Director
Ian Mortimer
President, Chief Financial Officer and Principal Accounting Officer
$638,674
$1,115,534
$28,876
$1,783,084
Ian Mortimer
$1,783,084
President, Chief Financial Officer and Principal Accounting Officer
Ernesto Aycardi
Chief Medical Officer
$582,498
$500,067
$24,174
$1,106,739
Ernesto Aycardi
$1,106,739
Chief Medical Officer
Michael Tarnow
Chairman of the Board
$77,799
$86,588
$0
$164,387
Michael Tarnow
$164,387
Chairman of the Board
Patrick Machado
Independent Director
$6,216
$156,758
$0
$162,974
Patrick Machado
$162,974
Independent Director
Xenon Pharmaceuticals Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2020. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us